-
Fresenius companies fined £550,000 by U.K. court in patient deathFresenius Kabiand a sister company were ordered by a U.K. court on Thursday to pay more than $860,000 in penalties after a diabetic patient died because the syringes the companies supplied contained n2015/7/10
-
CFDA issues announcement on record filing of clinical trials of medical devicesIn order to standardize the record filing of clinical trials of medical devices and enhance the supervision and management of medical device clinical trials, China Food and Drug Administration (CFDA)2015/7/9
-
AZ's Bydureon tops doc-payments list with $22BWhen it comes to which brands spent the most on doctor payments, 2014 crowned a new king--and that's diabetes drugBydureon. Maker AstraZeneca ($AZN) shelled out $22 million, helping the med eclipse No2015/7/9
-
Maryland Rep joins chorus of Amphastar critics, urging OD drug price dealAmphastar ($AMPH) is in hot water with U.S. officials again. After New York and other states put the squeeze on the company to drop the price of its overdose drug, naloxone, Rep. Elijah Cummings of Ma2015/7/9
-
Mylan didn't disclose director's ties to HQ land deal: WSJBack in late 2013, Mylan ($MYL) moved into a new headquarters in an office park near Pittsburgh--a 5-story building for about 700 employees. The main developer of that office park? Company Vice Chair2015/7/8
-
Novartis nabs early FDA approval for 'megablockbuster' EntrestoIt was a hotly anticipated pipeline drug. Now, Novartis' heart failure remedy Entresto is a hot new approval. The FDA gave its blessing 6 weeks early, and now the former LCZ696 can get ready to roll.2015/7/8
-
CFDA issues Good Supply Practice for Pharmaceutical Products (CFDA Order No. 13)The Good Supply Practice for Pharmaceutical Products (CFDA Order No. 13) was adopted at the executive meeting of China Food and Drug Administration (CFDA) on May 18, 2015, and was recently promulgated2015/7/7
-
Celgene throws down millions to snag prime airtime for its psoriasis-fighterAs the market forpsoriasismeds heats up, companies are throwing down some hefty chunks of change to snag airtime for their TV spots. And Celgene ($CELG), which markets Otezla, is the latest to join th2015/7/7
-
You want a formal offer, Mylan? Teva could have one this weekLast month, Mylan ChairmanRobert Courychallenged suitor Teva ($TEVA) to either put up a formal bid or step aside and let his company proceed with its plan to pursue its own target, Perrigo ($PRGO). An2015/7/7
-
CFDA Minister Bi Jingquan meets Cuban Ambassador to ChinaOn the afternoon of June 2, 2015, Bi Jingquan, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Alberto Jesus Blanco Silva, the Cuban Ambassador to China. Both sid2015/7/6